HERAMED LIMITED

Analyst Reco. HeraMED Limited

Equities

HMD

AU0000028367

Market Closed - Australian S.E. Other stock markets 05:50:07 02/04/2024 BST			5-day change	1st Jan Change
0.0175 ^AUD	-12.50%		-.--%	-27.08%

05-08	HeraMED Obtains ASIC Approval for Extension to Hold 2024 Meeting	MT
03-13	HeraMED Partners With FemBridge for Maternity Health Service; Shares Jump 15%	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HeraMED's Clinical Trial Results for Fetal Heart Rate Monitor Published in Peer-Reviewed Journal	08/11/22	MT
HeraMED Confirms Effectivity of Fetal Heart Rate Monitoring Device	19/07/22	MT
HeraMED Limited Provide an Update on the Trial of Smart Medical Grade Foetal Heart Rate Monitor HeraBEAT, and Cloud Based SaaS Pregnancy Monitoring Platform HeraCARE PRO	28/08/19	CI
Heramed Limited Launches Its Medical Grade Foetal Heart Rate Monitor, HeraBEAT	19/06/19	CI
HeraMED Limited Submits 510K Application to the US Food and Drug Administration to Seek FDA Approval for its Medical Grade, Foetal Heart Rate Monitor, the HeraBEAT	28/04/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer